Trade and other receivables and other current assets - additional details (Details) |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2024
EUR (€)
item
|
Dec. 31, 2025
EUR (€)
|
|
| Disclosure of analysis of single amount of off-balance sheet arrangements [line items] | |||
| Increase (Decrease) in deferred charges | $ | $ (15,000,000) | ||
| Financial assets | € 3,494,788,000 | € 3,133,264,000 | |
| Trade receivables | Accumulated impairment [member] | |||
| Disclosure of analysis of single amount of off-balance sheet arrangements [line items] | |||
| Financial assets | € (9,600,000) | ||
| Number Of Disputed Invoices | item | 2 | ||
| X | ||||||||||
- Definition The amount of increase decrease in deferred charges due to funding paid to Adaptimmune. No definition available.
|
| X | ||||||||||
- Definition Number of disputed invoices. No definition available.
|
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity’s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity’s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity’s own equity instruments. For this purpose the entity’s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity’s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|